Otolaryngology for the Future Surgeon
Course Number: OTO404

Offered by:
Daniel Karakla, M.D.
Department of Otolaryngology-Head & Neck Surgery
SNGH – River Pavilion, Suite #1100

Location: Departmental Offices-SNGH CHKD 

Periods Offered: Continuously

Duration: 4 weeks 

Number of Students: 1-2 

Student Level: Year 3-4 

Night Call: No

Report First Day: Students should page the Otolaryngology-Head & Neck Surgery Chief Resident for instructions the week before beginning the rotation.

Course Description: This elective offers an orientation to otolaryngology for the future surgeon. An emphasis will be placed on medical and surgical aspects of diseases of the head and neck with the development of specific surgical skills related to these diseases. The course will be divided between
operating room experiences and office otolaryngology. The elective will be fashioned to meet the needs of the student, and be tailored toward medical students interested in the Otolaryngology-Head & Neck Surgery residency.

Distribution of Student's Efforts: Patient Contact: 40% Inpatient, 60% Outpatient, Conferences three hours per week, Rounds 4 hours per week, study and reading time provided. Faculty contact 40 hours per week.

1. Learn the basics of the ear, nose and throat examination.
2. Diagnose and treat the spectrum of diseases related to chronic serous otitis media, acute otitis media and chronic otitis media.
3. Diagnose and treat the spectrum of diseases related to tonsillitis, adenoiditis and sinusitis.
4. Evaluate and treat nasal/sinus disorders.
5. Learn the basic work-up and follow-up of the head and neck cancer patient and thyroid/parathyroid patient.
6. Diagnose and treat voice and swallowing problems.
7. Develop surgical skills, such as performing myringotomy, tympanostomy tube placement, sinus irrigation, laryngoscopy, wound closure and tracheotomy.
8. To understand practical head and neck anatomy as it relates to the patient with surgical disease.
9. To understand the preop and postop care of patients with head and neck cancer.

Evaluation: 100% clinical observation.